Comunicação digital como ferramenta de educação permanente frente à COVID-19 na região sul de São Paulo / Digital communication as a tool for permanent education facing COVID-19 in the southern region of São Paulo

A OSS Associação Saúde da Família (ASF), responsável por cinco contratos de gestão no município de São Paulo, dentre eles os de Capela do Socorro e Parelheiros.Com o início da pandemia no Brasil e com a distribuição de 174 smartphones à cada equipe de atenção básica e 1167 tablets distribuídos para os ACS com chips e acesso à internet, entendemos que a comunicação seria um grande instrumento de alinhamento de informação e de alcance para materiais de Educação Permanente. Entre outras estratégias o Boletim de Situação  que os profissionais recebem em tempo real contendo as principais informações e solicitações do momento, compilados de forma simplificada. Entre estas informações enviadas estão os protocolos, documentos norteadores, vídeos e podcasts que possibilitam atuação de forma oportuna no cuidado da COVID-19.Acreditamos que toda construção descrita nos fez alcançar  o de menor mortalidade nas áreas de maior contaminação da cidade

Programa de Capacitação Permanente de Conselheiros Populares de Saúde na cidade de São Paulo

The popular health movement from São Paulo City has been electing Popular Health Councils since 1979. The issue of political and technical capabilities of its leaders has been an important point for the movement. During the years 1993 to 2000, the communication channels between the municipal government and popular leadership have been broken, leading back the social movement related to public health. However, in the beginningof 1988, the organized health movements located both at the east and southeast parts of São Paulo City, were succeeded in electing 1.039 members for those popular councils. After several scattered efforts to provide capability and skills to the councilors, it was decided to join the different regions and movements in only one project named Permanent Skills Improvement Course for elected representatives to the municipal health councils. The Ministry of Health and the Center for Permanent Education of the School of Public Health of Public Health of the University of São Paulo, Brazil, sponsored the initiative, with an amount of 52 courses attended by 1.011 councilors. This article contains both a description of the course process and the councilors social profiles, besides theirs evaluation over the initiative.O Movimento Popular de Saúde do Município de São Paulo vem elegendo Conselhos Populares de Saúde desde 1979. A questão da formação política e capacitação técnica de lideranças sempre foi uma preocupação do movimento de saúde. Durante a gestão municipal de 1993 a 2000 a interlocução entre o governo local e a representação popular foi rompida e disto decorreu um período de refluxo dos movimentos sociais. Porém, no início de 1998, os movimentos organizados de saúde das regiões leste e sudeste conseguiram se articular para eleger conselheiros para os Conselhos Populares de Saúde. Foram eleitos 1.039 conselheiros. Após vários esforços isolados de capacitação de conselheiros optou-se por realizar um Programa de Capacitação Permanente de Conselheiros de Saúde como forma de envolver o conjunto de bairros e regiões. Por meio de um convênio entre o Ministério da Saúde e o Centro de Educação Permanente da Faculdade de Saúde Pública da Universidade de São Paulo foram realizados 52 cursos para 1.011 desses conselheiros eleitos. Neste trabalho, a partir de análise documental, os autores descrevem esse processo de capacitação, caracterizam o perfil sócio econômico dos conselheiros e analisam a avaliação dos participantes nos cursos de capacitação

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701